BioNTech SE (22UA.F)

EUR 107.0

(-2.28%)

Net Income Summary of BioNTech SE

BioNTech SE's latest annual net income in 2023 was 930.3 Million EUR , down -90.14% from previous year.
BioNTech SE's latest quarterly net income in 2024 Q2 was -811.88 Million EUR , down -156.15% from previous quarter.
BioNTech SE reported an annual net income of 9.43 Billion EUR in 2022, down -8.34% from previous year.
BioNTech SE reported an annual net income of 10.29 Billion EUR in 2021, up 67613.82% from previous year.
BioNTech SE reported a quarterly net income of -316.95 Million EUR for 2024 Q1, down -169.22% from previous quarter.
BioNTech SE reported a quarterly net income of -190.4 Million EUR for 2023 Q2, down -137.91% from previous quarter.

Annual Net Income Chart of BioNTech SE (2023 - 2017)

Historical Annual Net Income of BioNTech SE (2023 - 2017)

Year	Net Income	Net Income Growth
2023	930.3 Million EUR	-90.14%
2022	9.43 Billion EUR	-8.34%
2021	10.29 Billion EUR	67613.82%
2020	15.2 Million EUR	108.48%
2019	-179.17 Million EUR	-273.13%
2018	-48.01 Million EUR	43.94%
2017	-85.65 Million EUR	0.0%

Year	Net Income	Net Income Growth
2024 Q2	-811.88 Million EUR	-156.15%
2024 Q1	-316.95 Million EUR	-169.22%
2023 Q2	-190.4 Million EUR	-137.91%
2023 Q4	457.9 Million EUR	185.12%
2023 FY	930.3 Million EUR	-90.14%
2023 Q3	160.6 Million EUR	184.35%
2023 Q1	502.2 Million EUR	-77.96%
2022 Q4	2.27 Billion EUR	27.67%
2022 Q2	1.67 Billion EUR	-54.8%
2022 Q1	3.69 Billion EUR	16.82%
2022 FY	9.43 Billion EUR	-8.34%
2022 Q3	1.78 Billion EUR	6.75%
2021 Q3	3.21 Billion EUR	15.21%
2021 Q1	1.12 Billion EUR	207.46%
2021 Q2	2.78 Billion EUR	147.07%
2021 FY	10.29 Billion EUR	67613.82%
2021 Q4	3.16 Billion EUR	-1.4%
2020 FY	15.2 Million EUR	108.48%
2020 Q4	366.91 Million EUR	274.69%
2020 Q3	-210.03 Million EUR	-137.87%
2020 Q2	-88.29 Million EUR	-65.39%
2020 Q1	-53.38 Million EUR	8.31%
2019 Q1	-40.64 Million EUR	-2906.36%
2019 Q3	-30.1 Million EUR	39.89%
2019 Q4	-58.22 Million EUR	-93.41%
2019 FY	-179.17 Million EUR	-273.13%
2019 Q2	-50.08 Million EUR	-23.22%
2018 Q2	-11.61 Million EUR	0.0%
2018 Q1	-11.61 Million EUR	0.0%
2018 Q3	-23.43 Million EUR	-101.7%
2018 Q4	-1.35 Million EUR	94.23%
2018 FY	-48.01 Million EUR	43.94%
2017 FY	-85.65 Million EUR	0.0%

Peer Net Income Comparison of BioNTech SE

Name	Net Income	Net Income Difference
CureVac N.V.	-260.16 Million EUR	457.578%
Biotest Aktiengesellschaft	127 Million EUR	-632.52%
Biotest Aktiengesellschaft	127 Million EUR	-632.52%
BRAIN Biotech AG	-8.27 Million EUR	11336.864%
Formycon AG	75.79 Million EUR	-1127.39%
Heidelberg Pharma AG	-20.34 Million EUR	4672.288%
Medigene AG	-16.17 Million EUR	5850.757%